Table 2.
Sexually transmitted infection positivity at repeat test-of-cure visits among human immunodeficiency virus-infected pregnant women, Pretoria, South Africa.
|
First test-of-cure (ToC1) |
Second test-of-cure (ToC2) |
Third test-of-cure (ToC3) |
||||
|---|---|---|---|---|---|---|
| Tested at ToC1 N | Positive at ToC1 n (%) | Tested at ToC2 N | Positive at ToC2 n (%) | Tested at ToC3 N | Positive at ToC3 n (%) | |
| Any CT, NG or TV at baseline | 136 | 36 (26.5%) | 29 | 14 (48.3%) | 9 | 7 (77.8%) |
| CT positive at baseline | 102 | 27 (26.5%) | 22 | 10 (45.5%) | 5 | 3 (60.0%) |
| NG positive at baseline | 16 | 1 (6.3%) | 1 | 0 | 0 | 0 |
| TV positive at baseline | 66 | 11 (16.7%) | 9 | 5 (55.6%) | 4 | 4 (100%) |
CT: Chlamydia trachomatis; NG: Neisseria gonorrhoeae; TV: Trichomonas vaginalis.